Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical results of IL-12 for chronic viral disease

April 30, 1997

NCI identifies compounds effective against aggressive human tumors

April 30, 1997

Neurex's blood pressure treatment up for FDA advisory panel review in June

April 29, 1997

TheraTech reacquires marketing rights to testosterone patch product

April 29, 1997

Joint venture created to develop calanolide A as anti-HIV treatment

April 29, 1997

Neuraminidase inhibitors highlighted at antiviral conference

April 29, 1997

ESI Lederle launches generic acyclovir

April 29, 1997

Target of action of AR-177 elucidated

April 29, 1997

MDL-101731 shows potent antiviral activity in vitro

April 29, 1997

Potent antitumor farnesyltransferase inhibitors discovered by Parke-Davis

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...